Urology Medical Lasers Global Market Report 2024

The urology medical lasers market size has grown steadily in recent years. It will grow from $1.01 billion in 2023 to $1.06 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The expansion observed in the historical period can be ascribed to swift technological advancements, a rise in healthcare spending, the rapid growth of the elderly population, reforms in public health insurance, and robust economic growth in emerging markets.

The urology medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.3 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The anticipated growth in the forecast period can be linked to a surge in mergers and acquisitions, elevated investment in research and development, and a focus on innovations, along with government initiatives that will propel market expansion. Key trends expected in this period include the emergence of novel technologies, the integration of big data and artificial intelligence, the introduction of innovative laser treatments for benign prostatic hyperplasia, and the utilization of fiber-optics in laser technology.

The increasing prevalence of urological disorders is a significant factor driving the demand for the urology medical lasers market. A rise in urological cases, including conditions such as bladder cancer and prostate diseases, is fostering the need for minimally invasive surgeries and associated devices. According to statistics from the American Institute for Cancer Research, bladder cancer ranks as the sixth most common cancer in men and the 17th most common cancer in women. This upsurge in urological diseases and conditions is fueling the demand for urological surgeries, thereby supporting the growth of the urology medical lasers market.

The continued growth in the incidence of urologic conditions is anticipated to propel the urology medical lasers market further. Urologic conditions encompass a range of issues affecting the reproductive or urinary tract systems in both males and females. Common urologic diseases include kidney stones, urinary tract infections, bladder control problems, and prostate issues. Urologists utilize laser instruments in the field of urology to diagnose and treat these conditions through various procedures. For instance, the American Cancer Society's Cancer Facts and Figures 2023 report reveals approximately 82,290 new cases of bladder cancer and 16,710 deaths from bladder cancer in the United States in 2023. Additionally, in 2021, the Centers for Disease Control and Prevention reported around 24,710 catheter-associated urinary tract infections in the U.S. The rising incidence of urologic conditions is a key driver for the urology medical lasers market.


Prominent institutions in the urology medical lasers market are actively advancing technologies such as the Litho EVO holmium laser. Designed for laparoscopic and endoscopic surgical procedures in urology, gastroenterology, and general surgery, Litho EVO is specifically indicated for lithotripsy and soft tissue procedures. Notably, in January 2021, Quanta System, an Italian-based company specializing in innovative laser systems for surgery, aesthetics, and art conservation, introduced the Litho EVO holmium laser in collaboration with Cook Medical. This advanced laser technology is now available in the United States, Austria, Germany, France, Ireland, Switzerland, and the United Kingdom. The Litho EVO laser boasts exclusive features such as Master PULSE and Vapor Tunnel™ technologies, distinctive to Quanta-branded machines.

In September 2021, Boston Scientific, a biomedical engineering company based in the United States, successfully acquired Lumenis Ltd for an undisclosed sum. This strategic acquisition integrates Lumenis's laser portfolio into Boston Scientific's offerings for kidney stone management and benign prostatic hyperplasia. Lumenis, headquartered in Israel, is renowned for manufacturing energy-based medical


Major companies operating in the urology medical lasers market report are Olympus Corporation, Boston Scientific Corporation, Lumenis Ltd., Richard Wolf GmbH, Quanta System S.p.A., Stryker Corporation, OmniGuide Holdings Inc., Convergent Laser Technologies, Biolitec AG, Allengers Medical Systems Limited, Changzhou Meditech Trading Co. Ltd., Shuzhou Sunan Zimmered Medical Instrument Co. Ltd., Narang Medical Limited, Atlas Surgical, Auxein Medical, Seikagaku Corporation, Anatomics, SignatureOrtho, Fresenius Medical Care AG & Co, KARL STORZ, EndoMed Systems GmbH, Dornier MedTech, Braun Melsungen AG, Lisa Laser, IRE-Polus, IPG Photonics Co, Capital Clinic Riga, Nick Mertziotis MDPh.D, Moscow Next Generation Clinic, Private Gürlife Hospital, Warsaw Surgery Clinic, Laser Med Medical Centre, Clinica Tambre, Stereotactic Radiosurgery Center ‘SIGULDA’, Cook Medical Incorporated, CR Bard, Healthtronics Inc., Surgical Lasers Inc., Medtronic, Aerolase, cutera, Cynosure Inc., Sciton Inc., Sharplight Technologies, Syneron Medical Inc., SoltaMedical Inc., Alma Lasers, Euracare.

North America was the largest region in the urology medical lasers market in 2023. Asia-Pacific was the second largest region in the urology medical lasers report. The regions covered in the urology medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the urology medical lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain. The urology medical lasers market consists of sales of holmium laser system, diode laser system, thulium laser system, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The urology medical lasers market encompasses various types, with notable examples being the holmium laser system, diode laser system, thulium laser system, and others. Holmium laser systems are specifically employed for the removal of stones in the bladder, kidneys, ureters, or urethra through laser-based procedures. The applications of these lasers extend to treating conditions such as benign prostatic hyperplasia (BPH), urolithiasis, non-muscle-invasive bladder cancer (NMIBC), and others. The primary end-users of urology medical lasers include hospitals, clinics, and other healthcare facilities.

The urology medical lasers market research report is one of a series of new reports that provides urology medical lasers market statistics, including urology medical lasers industry global market size, regional shares, competitors with a urology medical lasers market share, detailed urology medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the urology medical lasers industry. This urology medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.